# Anesthetic and Analgesic Drug Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments; Correction
**AGENCY:**
Food and Drug Administration, HHS.
**ACTION:**
Notice; correction.
**SUMMARY:**
The Food and Drug Administration is correcting a notice entitled “Anesthetic and Analgesic Drug Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments” that appeared in the *Federal Register* of September 11, 2018. The document announced a forthcoming public advisory committee meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and establishment of a public docket for comments. The document was published with the incorrect docket number. This document corrects that error.
**FOR FURTHER INFORMATION CONTACT:**
Lisa Granger, Office of Policy and Planning, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 3330, Silver Spring, MD 20993-0002, 301-796-9115.
**SUPPLEMENTARY INFORMATION:**
In the *Federal Register* of Tuesday, September 11, 2018 (83 FR 45941), in FR Doc. 2018-19667, on page 45941, the following correction is made:
On page 45941, in the first column, in the header of the document, and also in the third column under *Instructions,* “Docket No. FDA-2018-N-3276” is corrected to read “Docket No. FDA-2018-N-3431”.
Dated: September 11, 2018.
Leslie Kux,
Associate Commissioner for Policy.